Montenegro #3030 (v.4)
Datos básicos
- Notificada en
-
G/MA/QR/N/MNE/4 16/12/2025
- Validez de la versión
-
20/11/2025 -
actual
Versión activa actual v.4
- Miembro informante
- Montenegro
- En vigor desde
- Fecha de supresión
- En vigor
- Descripción general
-
Restriction on narcotic drugs and psychotropic substances
- Fundamento jurídico nacional
-
Law about preventing drugs abuse ("Official Gazette of Montenegro" No. 28/11, 35/13 and 84/24).
- document in Montenegrin
(The first version of the regulation entered into force on 18 June 2011 (the latest version entered into force on 14 September 2024 and has been applied since 1 October 2024)).
Rulebook determining the list of drugs, psychotropic substances and plants that can be used for manufacturing of drugs ("Official Gazette of Montenegro" No. 41/18, No. 57/18, No. 123/21 and No. 90/23) - document in Montenegrin
(The first version of the regulation entered into force on 6 July 2018 (the latest version entered into force on 14 October 2023)).
Decision on amending Control list for export and import of goods ("Official Gazette of Montenegro" No. 55/23)
(The first version of the regulation entered into force on 24 May 2014, and the current version has been in force since 9 June 2023.)
- Mecanismo administrativo
-
All exports and imports of medicines that contain narcotic drugs and psychotropic substances require a license issued by the Institute for Medicines and Medical Devices.
- Entidades responsables
-
Agency for Medicines and Medical Devices
- Versión del SA
-
HS 2022
- Signatura de la OMC a que se hace referencia
Metadatos
- Justificaciones en el marco de la OMC
-
XX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Notificada como: Article XX (b) of the GATT - Compromisos Internacionales (distintos de los asumidos en el marco de la OMC)
-
Single Convention (1961) on Narcotic Drugs
Notificada como: UN Single Convention on Narcotic Drugs 1961Convention (1971) on Psychotropic Substances
Notificada como: UN Convention on Psychotropic Substances 1971 - Interlocutores afectados
- Interlocutores no afectados
Medidas
- Restricciones notificadas
- NAL GQC NAL-X GQC-X
| Signatura |
|---|
|
GQC-X
|
|
GQC
|
|
NAL
|
|
NAL-X
|
Líneas arancelarias
|
121130
|
1211 30 00
|
Narcotic drugs (group 3)
|
|
|
121140
|
1211 40 00
|
Narcotic drugs (group 1)
|
|
|
121190
|
1211 90 86
|
Narcotic drugs (group 1)
Narcotic drugs (group 3) |
|
|
130190
|
1301 90 00
|
Narcotic drugs (group 1)
Narcotic drugs (group 3) |
|
|
130211
|
1302 11 00
|
Narcotic drugs (group 1)
|
|
|
130219
|
1302 19 70
|
Narcotic drugs (group 1)
|
|
|
290551
|
2905 51 00
|
Psychotropic substances (group 4)
|
|
|
290729
|
2907 29 00
|
Synthetic substances
|
|
|
291819
|
2918 19 98
|
Psychotropic substances (group 4)
|
|
|
292146
|
2921 46 00
|
Psychotropic substances (group 2)
Psychotropic substances (group 4) |
|
|
292149
|
2921 49 00
|
Psychotropic substances (group 1)
Synthetic substances |
|
|
292214
|
2922 14 00
|
Narcotic drugs (group 2)
|
|
|
292216
|
2922 16 00
|
Narcotic drugs (group 1)
|
|
|
292229
|
2922 29 00
|
Psychotropic substances (group 1)
Psychotropic substances (group 2) |
|
|
292231
|
2922 31 00
|
Narcotic drugs (group 1)
Psychotropic substances (group 4) |
|
|
292244
|
2922 44 00
|
Narcotic drugs (group 1)
|
|
|
292249
|
2922 49 85
|
Psychotropic substances (group 2)
|
|
|
292250
|
2922 50 00
|
Narcotic drugs (group 3)
|
|
|
292411
|
2924 11 00
|
Psychotropic substances (group 4)
|
|
|
292424
|
2924 24 00
|
Psychotropic substances (group 4)
|
|